vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $151.7M, roughly 1.5× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 5.8%, a 2.0% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-19.2M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 9.5%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
NUTX vs UTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $220.8M |
| Net Profit | $11.8M | $12.8M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | 7.1% |
| Net Margin | 7.8% | 5.8% |
| Revenue YoY | -41.1% | 9.6% |
| Net Profit YoY | -80.8% | -42.1% |
| EPS (diluted) | $2.34 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $220.8M | ||
| Q3 25 | $267.8M | $222.4M | ||
| Q2 25 | $244.0M | $204.3M | ||
| Q1 25 | $211.8M | $207.4M | ||
| Q4 24 | $257.6M | $201.4M | ||
| Q3 24 | $78.8M | $196.4M | ||
| Q2 24 | $76.1M | $177.5M | ||
| Q1 24 | $67.5M | $184.2M |
| Q4 25 | $11.8M | $12.8M | ||
| Q3 25 | $55.4M | $18.8M | ||
| Q2 25 | $-17.7M | $10.7M | ||
| Q1 25 | $21.2M | $11.4M | ||
| Q4 24 | $61.6M | $22.2M | ||
| Q3 24 | $-8.8M | $18.8M | ||
| Q2 24 | $-364.0K | $5.0M | ||
| Q1 24 | $-364.0K | $7.8M |
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 15.1% | — |
| Q4 25 | 20.4% | 7.1% | ||
| Q3 25 | 48.7% | 11.2% | ||
| Q2 25 | 13.8% | 6.9% | ||
| Q1 25 | 38.1% | 8.1% | ||
| Q4 24 | 44.4% | 13.6% | ||
| Q3 24 | 12.3% | 13.3% | ||
| Q2 24 | 7.0% | 4.2% | ||
| Q1 24 | 2.1% | 6.1% |
| Q4 25 | 7.8% | 5.8% | ||
| Q3 25 | 20.7% | 8.4% | ||
| Q2 25 | -7.3% | 5.2% | ||
| Q1 25 | 10.0% | 5.5% | ||
| Q4 24 | 23.9% | 11.0% | ||
| Q3 24 | -11.2% | 9.6% | ||
| Q2 24 | -0.5% | 2.8% | ||
| Q1 24 | -0.5% | 4.2% |
| Q4 25 | $2.34 | $0.23 | ||
| Q3 25 | $7.76 | $0.33 | ||
| Q2 25 | $-2.95 | $0.19 | ||
| Q1 25 | $3.33 | $0.21 | ||
| Q4 24 | $11.56 | $0.40 | ||
| Q3 24 | $-1.72 | $0.35 | ||
| Q2 24 | $-0.07 | $0.09 | ||
| Q1 24 | $-0.08 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $162.8M |
| Total DebtLower is stronger | — | $101.4M |
| Stockholders' EquityBook value | $329.4M | $335.9M |
| Total Assets | $918.5M | $834.0M |
| Debt / EquityLower = less leverage | — | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $162.8M | ||
| Q3 25 | $166.0M | $169.1M | ||
| Q2 25 | $96.7M | $70.7M | ||
| Q1 25 | $84.7M | $96.0M | ||
| Q4 24 | $40.6M | $172.0M | ||
| Q3 24 | $46.9M | $161.9M | ||
| Q2 24 | $40.8M | $115.5M | ||
| Q1 24 | $30.0M | $116.1M |
| Q4 25 | — | $101.4M | ||
| Q3 25 | — | $87.1M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $94.4M | ||
| Q4 24 | — | $120.1M | ||
| Q3 24 | — | $125.7M | ||
| Q2 24 | — | $137.3M | ||
| Q1 24 | — | $141.9M |
| Q4 25 | $329.4M | $335.9M | ||
| Q3 25 | $317.2M | $328.1M | ||
| Q2 25 | $235.3M | $306.8M | ||
| Q1 25 | $176.9M | $293.9M | ||
| Q4 24 | $132.4M | $280.0M | ||
| Q3 24 | $60.4M | $260.2M | ||
| Q2 24 | $62.7M | $239.4M | ||
| Q1 24 | $63.0M | $232.6M |
| Q4 25 | $918.5M | $834.0M | ||
| Q3 25 | $964.5M | $826.1M | ||
| Q2 25 | $841.0M | $740.8M | ||
| Q1 25 | $761.9M | $720.4M | ||
| Q4 24 | $655.3M | $753.8M | ||
| Q3 24 | $438.5M | $744.6M | ||
| Q2 24 | $422.4M | $706.0M | ||
| Q1 24 | $404.3M | $702.1M |
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $3.1M |
| Free Cash FlowOCF − Capex | $69.0M | $-19.2M |
| FCF MarginFCF / Revenue | 45.5% | -8.7% |
| Capex IntensityCapex / Revenue | 0.9% | 10.1% |
| Cash ConversionOCF / Net Profit | 5.95× | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $3.1M | ||
| Q3 25 | $99.5M | $57.1M | ||
| Q2 25 | $27.3M | $18.1M | ||
| Q1 25 | $51.0M | $-789.0K | ||
| Q4 24 | $54.0K | $23.0M | ||
| Q3 24 | $6.8M | $67.5M | ||
| Q2 24 | $13.3M | $10.0M | ||
| Q1 24 | $3.1M | $-2.5M |
| Q4 25 | $69.0M | $-19.2M | ||
| Q3 25 | $99.2M | $40.6M | ||
| Q2 25 | $26.5M | $6.8M | ||
| Q1 25 | $50.9M | $-11.7M | ||
| Q4 24 | $-341.0K | $19.6M | ||
| Q3 24 | $6.2M | $60.0M | ||
| Q2 24 | $12.7M | $3.0M | ||
| Q1 24 | $2.3M | $-8.4M |
| Q4 25 | 45.5% | -8.7% | ||
| Q3 25 | 37.0% | 18.3% | ||
| Q2 25 | 10.9% | 3.4% | ||
| Q1 25 | 24.0% | -5.7% | ||
| Q4 24 | -0.1% | 9.7% | ||
| Q3 24 | 7.8% | 30.6% | ||
| Q2 24 | 16.7% | 1.7% | ||
| Q1 24 | 3.4% | -4.6% |
| Q4 25 | 0.9% | 10.1% | ||
| Q3 25 | 0.1% | 7.4% | ||
| Q2 25 | 0.3% | 5.5% | ||
| Q1 25 | 0.0% | 5.3% | ||
| Q4 24 | 0.2% | 1.7% | ||
| Q3 24 | 0.8% | 3.8% | ||
| Q2 24 | 0.7% | 4.0% | ||
| Q1 24 | 1.1% | 3.2% |
| Q4 25 | 5.95× | 0.24× | ||
| Q3 25 | 1.80× | 3.04× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | 2.40× | -0.07× | ||
| Q4 24 | 0.00× | 1.04× | ||
| Q3 24 | — | 3.58× | ||
| Q2 24 | — | 2.01× | ||
| Q1 24 | — | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
